SABBY 13G OXBT 03.18.14

Company

TENAX THERAPEUTICS, INC.

Filed

March 18, 2014

Accession Number

0001535610-14-000049

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →